Table 2.
Follow up of patients assuming Cimicifuga.
| Parameter | Values |
|---|---|
| Physical examination | |
| BMI | 28.5 (SD 0.71) |
| Blood pressure | |
| systolic | 125 (SD 7.07) |
| diastolic | 75 (SD 21.21) |
| Heart rate | 76.5 (SD 0.71) |
| Few patients (9/107) were suffering of minor complaints, that revalued after 1 month did not show any sign of liver disease | |
| Abdominal pain | 5 (4.6%) |
| Paresthesias | 3 (2.8%) |
| Fatigue | 2 (1.8%) |
| Anorexia | 1 (0.9%) |
| Myalgia | 1 (0.9%) |
| Malaise | 1 (0.9%) |
| Pruritus | 1 (0.9%) |
| Fever | 0 |
| Skin rash | 0 |
| Jaundice | 0 |
| Laboratory findings | |
| Leukocyte total count | 4250 mm3 (SD 1060) |
| Bilirubin | 0.75 mg dl−1 (SD 0.07) |
| AST | 29.5 IU−1 (SD 10.61) |
| ALT | 15.5 IU l−1 (SD 17.68) |
| Alkaline Phosphatase | 135 U l−1 (SD 63.64) |
| GGT | 28 U l−1 (SD 7.07) |
| Albumin | 3.75 g dl−1 (SD 0.49) |
| INR | 1 (SD 0.14) |